Future of the Meningococcal Vaccines Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Meningococcal Vaccines Market Size Growth Forecast: What to Expect by 2025?
In recent times, the dimension of the meningococcal vaccines market has seen robust expansion. It is projected to swell from $3.89 billion in 2024 to $4.26 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. Factors such as disease prevalence, worldwide travel patterns, healthcare facilities, readiness for epidemics, and health insurance coverage fuelled this growth in the past.

How Will the Meningococcal Vaccines Market Size Evolve and Grow by 2029?
A significant surge is expected in the meningococcal vaccines market size in the upcoming years, with a projection to reach "$6.05 billion in 2029, experiencing a 9.2% Compound Annual Growth Rate (CAGR). The expansion in the predicted period is due to factors such as the advent of fresh strains, intensifying globalization, increasing healthcare investments, health initiatives, and evolving regulatory scenarios. Foreseen trends for this period comprise personalized vaccines, digital immunization records, gene modification technologies, multi-valent vaccines, and subscription-centered vaccine models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

What Drivers Are Propelling the Growth of Meningococcal Vaccines Market Forward?
The surge in healthcare expenditure is anticipated to catalyze the expansion of the meningococcal vaccine market. When referring to healthcare, it covers a spectrum of institutions such as residential care facilities, nursing units, intermediate facilities for the mentally ill or those with intellectual disabilities. The rising costs of advanced generations of vaccines compared to their earlier versions have sparked debates surrounding the justification of their prices based on their benefits. The whole-scale evaluation of the social and economic positives from vaccination is becoming a more crucial subject in the study pertaining to vaccine valuation. For example, a research piece published by the American Medical Association in May 2022 highlighted that healthcare expenses in the US had witnessed a 9.7% increase, amounting to $4.1 trillion or $12,530 per person. This growth rate notably exceeds the one from 2019 (4.3%). Hence, the surge in healthcare expenditure is a key driver of growth in the meningococcal vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8013&type=smp

What Are the Key Trends Driving Meningococcal Vaccines Market Growth?
Leading companies in the meningococcal vaccines market are innovating new vaccines targeted at preventing various serogroups to enhance their market profitability. Meningococcal vaccines serve as defensive strategies against infections induced by specific Neisseria meningitidis serogroups. In October 2023, Pfizer Inc., an American pharmaceutical firm, obtained FDA approval for their vaccine PENBRAYA. With its broad-ranging serogroup coverage, PENBRAYA has become the most comprehensive meningococcal vaccine approved in the U.S., providing protection against groups A, B, C, W, and Y. The FDA gave their approval based on strong evidences from Phase 2 and 3 trials, clarifying its equivalent immunogenicity to Trumenba + Menveo across all serogroups, along with a positive safety record. In September 2022, Pfizer announced the successful results of a Phase 3 trial that compared PENBRAYA with other existing licensed meningococcal vaccines regarding safety, tolerability, and immunogenicity.

What Are the Key Segments in the Meningococcal Vaccines Market?
The meningococcal vaccines market covered in this report is segmented -

1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel:: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes

Subsegments:
1) By Meningococcal Conjugate Vaccine: Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine
2) By Polysaccharide Vaccine: Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine
3) By Subcapsular Vaccine: Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8013&type=smp

Who Are the Key Players Shaping the Meningococcal Vaccines Market's Competitive Landscape?
Major companies operating in the meningococcal vaccines market include Pfizer Inc., GlaxoSmithKline plc, Sanofi Pasteur, Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Bio-Manguinhos, Walvax Biotechnology Co. Ltd., Bavarian Nordic A/S, Hualan Biological Engineering Inc., China National Pharmaceutical Group (Sinopharm), Bharat Biotech, Incepta Pharmaceuticals Ltd., Biological E. Limited, Chongqing Zhifei Biological Products Co. Ltd., Biokangtai, Biomed Pvt Ltd., Biocine SCL, Panacea Biotec Ltd., Grifols S.A., CSL Limited, Minhai Biotechnology Co. Ltd., Chiron Behring Vaccines Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd.

What Geographic Markets Are Powering Growth in the Meningococcal Vaccines Market?
North America was the largest region in the meningococcal vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the meningococcal vaccines market report during the forecast period. The regions covered in the meningococcal vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8013

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.